[{"Assets_0_Q1_USD":"14256100000.0","CIK":"875320","CommonStockSharesIssued_0_Q1_shares":"255574961.0","CommonStockSharesOutstanding_0_Q1_shares":"255574961.0","Country":"United States","EarningsPerShareBasic_1_Q1_USD":"2.99","EarningsPerShareDiluted_1_Q1_USD":"2.96","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"72193451271.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":"956200000.0","NetIncomeLoss_1_Q1_USD":"762100000.0","OfficialName":"Vertex Pharmaceuticals Incorporated Common Stock","RevenuesConverted_1_Q1_USD":"2097500000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquity_0_Q1_USD":"10907000000.0","Ticker":"VRTX","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":"257900000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":"255100000.0","filed":"20220506","footnote":null,"form":"10-Q","fp":"Q1","fy":"2022.0","name":"VERTEX PHARMACEUTICALS INC \/ MA","period":"20220331","qtrs":"0","uom":"USD"}]